NCT03913442View on ClinicalTrials.gov

Colchicine for the Treatment of Osteoarthritis of the Knee

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 15, 2019

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
OsteoarthritisOsteo Arthritis Knee
Interventions
DRUG

Colchicine 0.8 mg or 0.6 mg orally once daily

Colchicine 0.8 mg orally once daily for 1.5 months, and then 0.6 mg once daily for the remainder of the time (1.5 months)

DRUG

Placebo oral capsule

Placebo 0.8 mg or 0.6 mg orally once daily for 3 months

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03913442 - Colchicine for the Treatment of Osteoarthritis of the Knee | Biotech Hunter | Biotech Hunter